Gregory Russotti Sells $25.7K of Century Therapeutics Inc (IPSC) — SEC Form 4, Mar 16, 2026
Open-Market Net Sale · SEC Form 4
−$25,684
Equity position changed by -1.6%
Equity Position
608K sh
618,276 → 608,200
Equity Change
-1.6%
shares held after vs before
Filing Lag
2 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Gregory Russotti CIK 0001867305 |
Officer
|
Gregory Russotti at Century Therapeutics Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$40,140
More from this insider at Century Therapeutics Inc
| 2026-09-15 | Sell | -$4,993 | View |
| 2026-09-09 | Sell | -$1,095 | View |
| 2026-06-15 | Sell | -$5,767 | View |
| 2026-06-09 | Sell | -$1,106 | View |
| 2026-03-11 | Sell | -$1,215 | View |
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common StockF1 | 2026-03-12 | S - Sale | 10,076 D | $2.55 | -$25,684 | 515,427 | Direct |
Non-Derivative Holdings
| Title | Shares Held | Ownership |
|---|---|---|
| Common Stock | 92,773 | Indirect By Gregory Russotti 2021 Family Trust |
Footnotes (1)
- F1
- The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person. Show more
Remarks
Title: Chief Technology and Manufacturing Officer
Show moreRelated filings at Century Therapeutics Inc
Institutional Holders
13F holders · Jun 30, 2026
100
institutional managers reporting a position
Largest by reported value
- Ra Capital Management, L.P. $43.5M
- Tcg Crossover Management, Llc $43.4M
- Versant Venture Management, Llc $29.8M
5%+ Holders · 13D/G
6 filers
Other insiders at Century Therapeutics Inc
GET /v1/forms/4/0001867305-26-000006
API docs
View Original SEC Filing